These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31386769)

  • 41. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
    Ishizuka M; Terasaki A; Kubota K
    J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
    Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
    Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
    Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
    Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
    Nakamura T; Ebihara I; Shimada N; Koide H
    Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracorporeal endotoxin removal in a canine model of septic shock.
    Lonergan JM; Orlowski JP; Sato T; McHugh MJ; Zborowski M
    ASAIO J; 1994; 40(3):M654-7. PubMed ID: 8555595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.
    Tani T; Shimizu T; Tani M; Shoji H; Endo Y
    Adv Exp Med Biol; 2019; 1145():321-341. PubMed ID: 31364085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental study of extracorporeal perfusion for septic shock.
    Sato T; Orlowski JP; Zborowski M
    ASAIO J; 1993; 39(3):M790-3. PubMed ID: 8268646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection.
    Suzuki Y; Kojika M; Sato H; Inoue Y; Endo S
    Ther Apher Dial; 2019 Feb; 23(1):80-85. PubMed ID: 30209889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of sepsis during MARS treatment in acute on chronic liver failure.
    Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB
    Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Study of Endotoxin Adsorption by a Polymyxin B-Immobilized Fiber Column.
    Yamashita C; Moriyama K; Hasegawa D; Kato Y; Sakai T; Kawaji T; Shimomura Y; Kurimoto Y; Nagata M; Nishida O
    Blood Purif; 2018; 46(4):269-273. PubMed ID: 29969762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Kobayashi N; Koide H
    Blood Purif; 2005; 23(6):417-20. PubMed ID: 16141713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endotoxin and Cytokine Sequential Hemoadsorption in Septic Shock and Multi-Organ Failure.
    Ruiz-Rodríguez JC; Chiscano-Camón L; Palmada C; Ruiz-Sanmartin A; Pérez-Carrasco M; Larrosa N; González JJ; Hernández-González M; Ferrer R
    Blood Purif; 2022; 51(7):630-633. PubMed ID: 34515070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
    Martin EL; Ranieri VM
    Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
    Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
    J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.
    Vincent JL; Laterre PF; Cohen J; Burchardi H; Bruining H; Lerma FA; Wittebole X; De Backer D; Brett S; Marzo D; Nakamura H; John S
    Shock; 2005 May; 23(5):400-5. PubMed ID: 15834304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.
    Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC
    Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
    Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
    Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.